Scott Tarriff's Net Worth
$28.5 Million
Who is Scott Tarriff?
Scott Tarriff has an estimated net worth of $28.5 Million. This is based on reported shares across multiple companies, which include , Synthetic Biologics, Inc., ZIOPHARM ONCOLOGY INC, and CLINICAL DATA INC.
SEC CIK
Scott Tarriff's CIK is 0001469124
Past Insider Trading and Trends
2014 was Scott Tarriff's most active year for acquiring shares with 5 total transactions. Scott Tarriff's most active month to acquire stocks was the month of December. 2015 was Scott Tarriff's most active year for disposing of shares, totalling 23 transactions. Scott Tarriff's most active month to dispose stocks was the month of December. 2018 saw Scott Tarriff paying a total of $961,148.32 for 663,408 shares, this is the most they've acquired in one year. In 2015 Scott Tarriff cashed out on 216,222 shares for a total of $12,538,599.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ZIOPHARM ONCOLOGY INC (TCRT) Snapshot price: $2.16
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
∞
| 4.19K |
—
|
—
| 4.19K |
Sep 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EAGLE PHARMACEUTICALS, INC. (EGRX) No price found
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.46% | -2.12K |
$6.27 | -$13,286.13 | 460.62K |
Feb 28
| |||
Form 4
| +2.16% | 9.8K |
$6.44 | -$20,311.76 | 462.74K |
Feb 27
| |||
Form 4
| -0.79% | -4.32K |
$5.13 | -$22,171.86 | 541.13K |
Jan 5
| |||
Form 4
| -3.81% | -21.62K |
$13.84 | -$299,309.28 | 545.45K |
Scheduled
|
Nov 1 - Nov 2
| ||
Form 4
| -3.45% | -20.25K |
$14.82 | -$300,026.47 | 567.07K |
Oct 2 - Oct 3
| |||
Form 4
| -2.49% | -15.00K |
$19.98 | -$299,700.00 | 587.31K |
May 16
| |||
Form 4
| -2.74% | -45.00K |
$20.68 | -$930,656.37 | 1.59M |
May 11 - May 15
| |||
Form 4
| +4.31% | 67.79K |
$28.00 | -$87,164.00 | 1.64M |
Feb 28 - Mar 1
| |||
Form 4
| -0.24% | -3.73K |
$33.64 | -$125,544.48 | 1.57M |
Jan 23
| |||
Form 4
| -0.24% | -3.83K |
$29.26 | -$111,978.02 | 1.58M |
Jan 5
| |||
Form 4
| +2.25% | 34.8K |
—
|
—
| 1.58M |
Feb 28
| |||
Form 4
| -0.09% | -1.42K |
$25.33 | -$407,615.08 | 1.54M |
Feb 23 - Apr 1
| |||
Form 4
| -0.30% | -4.63K |
$47.70 | -$220,898.70 | 1.55M |
Jan 23
| |||
Form 4
| -0.48% | -7.55K |
$57.98 | -$437,633.04 | 1.55M |
Jan 23
| |||
Form 4
| +3.89% | 58.3K |
—
|
—
| 1.56M |
Jan 5
| |||
Form 4
| -1.64% | -24.98K |
$50.15 | -$1,252,496.25 | 1.5M |
Scheduled
|
Apr 1
| ||
Form 4
| -1.58% | -24.43K |
$51.17 | -$1,250,014.68 | 1.53M |
Scheduled
|
Mar 1
| ||
Form 4
| -1.90% | -30.09K |
$41.54 | -$1,249,831.20 | 1.55M |
Scheduled
|
Feb 1
| ||
Form 4
| +4.04% | 61.3K |
—
|
—
| 1.58M |
Jan 23
| |||
Form 4
| -2.04% | -31.57K |
$39.49 | -$1,246,763.02 | 1.52M |
Scheduled
|
Jan 2 - Jan 3
| ||
Form 4
| +8.76% | 124.8K |
$4.04 | $504,208.16 | 1.55M |
Jun 28
| |||
Form 4
| +4.03% | 55.21K |
$28.37 | -$2,593,547.39 | 1.43M |
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| -2.20% | -30.77K |
$40.63 | -$1,249,981.95 | 1.37M |
Scheduled
|
Apr 1
| ||
Form 4
| -1.39% | -19.78K |
$63.20 | -$1,250,027.96 | 1.4M |
Scheduled
|
Mar 1
| ||
Form 4
| -1.28% | -18.36K |
$68.08 | -$1,249,974.34 | 1.42M |
Scheduled
|
Feb 1
| ||
Form 4
| -1.00% | -14.55K |
$85.91 | -$1,249,920.86 | 1.44M |
Scheduled
|
Jan 4
| ||
Form 4
| -0.96% | -14.05K |
$88.93 | -$1,249,418.92 | 1.45M |
Scheduled
|
Dec 1
| ||
Form 4
| -1.30% | -19.34K |
$64.63 | -$1,249,954.91 | 1.47M |
Scheduled
|
Nov 2
| ||
Form 4
| -1.19% | -17.88K |
$69.92 | -$1,249,964.73 | 1.49M |
Scheduled
|
Oct 1
| ||
Form 4
| -1.07% | -16.25K |
$76.95 | -$1,249,998.04 | 1.5M |
Scheduled
|
Sep 1
| ||
Form 4
| -0.85% | -13.00K |
$96.19 | -$1,250,408.26 | 1.52M |
Scheduled
|
Aug 3
| ||
Form 4
| -8.13% | -135.71K |
$46.34 | -$6,288,854.74 | 1.53M |
Scheduled
|
Mar 20 - Jul 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 26
| |||
Form 4
| +13.40% | 197.25K |
—
|
—
| 1.67M |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Synthetic Biologics, Inc. (TOVX) Snapshot price: $0.5156
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 4
|
∞
| 300K |
—
|
—
| 300K |
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CLINICAL DATA INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -16.60K |
$30.00 | -$498,000.00 |
0
|
Apr 12 - Apr 13
| |||
Form 4
| +84.44% | 7.6K |
—
|
—
| 16.6K |
Sep 16
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 9K |
—
|
—
| 9K |
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||